ROIVANT SCIENCES LTD
ROIV·G76279101·US·Common Stock·Healthcare - Biotechnology-13D/G
ROIV (ROIVANT SCIENCES LTD) is held by 203 institutional investors as of Q2 2026. Largest holders: FMR LLC ($2.9B), BlackRock, Inc. ($1.7B), MORGAN STANLEY ($1.5B). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 125 funds bought ROIV.
203
Holders
(17 Elite)
$15.9B
Total Value
60% (208)
Consensus
125 buying - 83 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 24, 2026 · Activists Aug 13, 2026 · Congress Nov 21, 2025
InsiderSMSukhatme MayukhExercise 145K shAug 21, 2026
InsiderSMSukhatme MayukhSell $5.3MAug 21, 2026
InsiderSMSukhatme MayukhExercise 18K shAug 20, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 211
1 / 11
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer